ask="3.10"
ask_size="500"
average_daily_volume="4152510"
bid="3.01"
bid_size="300"
book_value="-1.75"
change="+0.06"
change_from_200_day_moving_average="-2.03"
change_from_50_day_moving_average="-1.06"
change_from_52_week_high="-5.94"
change_From_52_week_low="0.25"
change_in_percent="+1.99%"
close="3.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.23"
ex_dividend_date="N/A"
float_shares="122562000"
high="3.11"
high_52_weeks="9.02"
last_trade_date="1/27/2017"
last_trade_price="3.08"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="3.00"
low_52_weeks="2.83"
market_capitalization="399.21M"
moving_average_200_day="5.11"
moving_average_50_day="4.14"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.00"
pe_ratio="N/A"
peg_ratio="-0.46"
percent_change_from_200_day_moving_average="-39.70%"
percent_change_from_50_day_moving_average="-25.60%"
percent_change_from_52_week_high="-65.83%"
percent_change_from_52_week_low="+8.83%"
previous_close="3.02"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.75"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="14.12"
stock_exchange="NGM"
symbol="MACK"
volume="1410418"
weeks_range_52="2.83 - 9.02"
